Combined radiation therapy and dendritic cell vaccine for treating solid tumors with liver micro‐metastasis
- 6 December 2004
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 7 (4) , 506-517
- https://doi.org/10.1002/jgm.692
Abstract
Background Tumor metastasis and relapse are major obstacles in combating human malignant diseases. Neither radiotherapy alone nor injection of dendritic cells (DCs) can successfully overcome this problem. Radiation induces tumor cell apoptosis and necrosis, resulting in the release of tumor antigen and danger signals, which are favorable for DC capturing antigens and maturation. Hence, the strategy of combined irradiation and DC vaccine may be a novel approach for treating human malignancies and early metastasis. Methods To develop an effective combined therapeutic approach, we established a novel concomitant local tumor and liver metastases model through subcutaneous (s.c.) and intravenous (i.v.) injection. We selected the optimal time for DC injection after irradiation and investigated the antitumor effect of combining irradiation with DC intratumoral injection and the related mechanism. Results Combined treatment with radiotherapy and DC vaccine could induce a potent antitumor immune response, resulting in a significant decrease in the rate of local tumor relapse and the numbers of liver metastases. The related mechanisms for this strong antitumor immunity of this combined therapy might be associated with the production of apoptotic and necrotic tumor antigens and heat shock proteins after irradiation, phagocytosis, migration and maturation of DCs, and induction of more efficient tumor-specific cytotoxic T lymphocyte activity through a cross-presentation pathway. Conclusions Co-administration of local irradiation and intratumoral DC injection may be a promising strategy for treating radiosensitive tumors and eliminating metastasis in the clinic. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 46 references indexed in Scilit:
- Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanomaJournal of Experimental Therapeutics and Oncology, 2003
- Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in miceBone Marrow Transplantation, 2002
- The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosisCurrent Biology, 2001
- Antigen presentation to CD8+ T cells: cross-priming in infectious diseasesCurrent Opinion in Immunology, 2001
- Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivoOncogene, 2001
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000
- Consequences of Cell DeathThe Journal of Experimental Medicine, 2000
- Multiple MyelomaNew England Journal of Medicine, 1997
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Post-orchidectomy radiation therapy alone for patients with early stage non-seminomatous germ cell tumours of the testisAustralasian Radiology, 1995